P910001: ELCA CORONARY ATHERECTOMY CATHETERS

by SPECTRANETICS CORP.

Trade NameELCA CORONARY ATHERECTOMY CATHETERS
Generic NameCORONARY ANGIOPLASTY CATHETER
ApplicantSPECTRANETICS CORP.
PMA NumberP910001
Recent Supplement NumberS064
Contact
9965 FEDERAL DRIVE
COLORADO SPRINGS, CO, 80921
Date ReceivedJan 31, 2013
Decision DateFeb 28, 2013
Product CodeLPC
Advisory CommitteeCV
Supplement Type30-DAY NOTICE
Supplement ReasonPROCESS CHANGE: MANUFACTURING
Expedited Review Granted?N
Order Approval StatementCHANGE TO THE PROCESS FOR MONITORING THE ETHYLENE OXIDE STERILIZATION PROCESS.
sourcefda.gov
#Decision DateReason/TypeChange
S063Jan 08, 2013PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEALTERNATE SUPPLIER FOR CABLE ASSEMBLIES.
S062Dec 26, 2012PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEADDITION OF A NEW COMPUTER NUMERIC CONTROL (CNC) MACHINING TOOL.
S061Sep 05, 2012PROCESS CHANGE: STERILIZATION/30-DAY NOTICEUSE OF ADDITIONAL STERILIZATION CHAMBERS AT THE CONTRACT STERILIZER.
S060Jul 31, 2012PROCESS CHANGE: MANUFACTURING/30-DAY NOTICECHANGES TO THE ON-DEMAND LABEL PRINTING SYSTEM.
S058Jul 25, 2012PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEADDITION OF NEW EXTRUSION EQUIPMENT.
S057Jul 06, 2012PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEADDITION OF A COMPONENT SUPPLIER FOR THE DEVICE.
S056Jul 03, 2012DESIGN CHANGE - MINOR/REAL-TIME PROCESSAPPROVAL FOR A CHANGE TO THE RADIO FREQUENCY (RF) ABSORPTION MATERIAL FOR THE CVX-300P MODEL EXCIMER LASER.
S055May 30, 2012PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEAUTOMATION OF LOT NUMBER ASSIGNMENT FOR PRINTING.
S054May 02, 2012PROCESS CHANGE: STERILIZATION/30-DAY NOTICEMODIFICATION TO THE ETHYLENE OXIDE STERILIZATION CYCLE.
S053Feb 24, 2012PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEREMOVE REDUNDANT QUALITY CONTROL INSPECTION STEPS IN YOUR FIBER DRAW AND FIBER RE-SPOOLING MANUFACTURING PROCESSES.
S051Feb 17, 2012PROCESS CHANGE: STERILIZATION/135 REVIEW TRACK FOR 30-DAY NOTICEAPPROVAL FOR THE USE OF A NEW STERILIZATION CHAMBER, NEW STERILIZATION CYCLE, CHANGE IN PACKAGING CONFIGURATION FOR STERILIZATION, AND A CHANGE IN THE STERILE LOAD CONFIGURATION.
S047Jan 13, 2012LOCATION CHANGE: MANUFACTURER/NORMAL 180 DAY TRACK NO USER FEEAPPROVAL FOR A MANUFACTURING SITE LOCATED IN COLORADO SPRINGS, COLORADO.
S052Dec 27, 2011PROCESS CHANGE: STERILIZATION/30-DAY NOTICECHANGE IN EO STERILIZATION PROCESS MONITORING.
S050Dec 06, 2011CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - COMPONENT/REAL-TIME PROCESSAPPROVAL TO IMPLEMENT A CHANGE TO THE RADIO FREQUENCY (RF) ABSORPTION MATERIALS FOR THE CVX-300P MODEL EXCIMER LASER.
S040Nov 18, 2011LOCATION CHANGE: STERILIZER/NORMAL 180 DAY TRACK NO USER FEEAPPROVAL FOR A STERILIZATION SITE LOCATED AT CARIDIANBCT STERILIZATION SERVICES IN LAKEWOOD, COLORADO.
S049Oct 25, 2011CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/REAL-TIME PROCESSAPPROVAL FOR SOFTWARE CHANGES TO THE CVX-300 AND CVX-300-P LASER SYSTEMS.
S045Jul 14, 2011PROCESS CHANGE: MANUFACTURING/135 REVIEW TRACK FOR 30-DAY NOTICEAPPROVAL FOR CHANGES TO PYROGEN TESTING PROCEDURES AND SAMPLING.
S048Jun 08, 2011/30-DAY NOTICEADDITION OF AN ALTERNATE SUPPLIER FOR A DEVICE COMPONENT.
S042Apr 20, 2011PROCESS CHANGE: MANUFACTURING/135 REVIEW TRACK FOR 30-DAY NOTICEAPPROVAL TO IMPLEMENT THE USE OF AN AUTOMATED METHOD INSTEAD OF A MANUAL METHOD OF DISPENSING EPOXY ADHESIVE.
S044Feb 28, 2011PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEMODIFICATIONS TO THE GLASS PREFORM PROCESS.
S043Feb 03, 2011PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEUSE OF ADDITIONAL POUCH SEALING EQUIPMENT.
S034Jan 10, 2011LOCATION CHANGE: MANUFACTURER/NORMAL 180 DAY TRACK NO USER FEEAPPROVAL FOR A MANUFACTURING SITE LOCATED IN COLORADO SPRINGS, COLORADO.
S041Dec 29, 2010PROCESS CHANGE: MANUFACTURING/30-DAY NOTICECHANGE IN PROCESSING EQUIPMENT FROM HAND-ACTIVATED TO FOOT-ACTIVATED.
S038Nov 10, 2010PROCESS CHANGE: MANUFACTURING/30-DAY NOTICEADDITION OF AN ALTERNATE DI WATER SUPPLY.
S037Oct 15, 2010PROCESS CHANGE - OTHER/30-DAY NOTICECHANGE TO THE LABEL PRINTING PROCESS.
S033Jul 08, 2010CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACKAPPROVAL FOR CHANGES TO THE CVX-300 EXCIMER LASER SYSTEM FOR COMPLIANCE TO ELECTRICAL SAFETY AND ELECTROMAGNETIC COMPATIBILITY VOLUNTARY STANDARDS.
S032Jul 29, 2009CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - MATERIAL/REAL-TIME PROCESSAPPROVAL FOR A CHANGE IN THE MATERIAL OF THE PROXIMAL COUPLER COMPONENT OF THE ELCA CATHETERS.
S031Jun 01, 2009PROCESS CHANGE: PACKAGING/30-DAY NOTICECHANGES TO THE IN-PROCESS ACCEPTANCE ACTIVITIES FOR THE LABELING AND BOXING PROCESS.
S027Mar 25, 2009PROCESS CHANGE: MANUFACTURING/135 REVIEW TRACK FOR 30-DAY NOTICEAPPROVAL FOR: 1) REMOVAL OF BIOBURDEN TESTING FROM THE LOT HISTORY RECORDS (LHR) AS A TEST REQUIRED FOR RELEASE OF PRODUCT, AND 2) CHANGE LAL ENDOTOXIN TEST PROCEDURE TO INSTRUCT QUALITY ASSOCIATES TO COLLECT PRODUCT SAMPLE POST-STERILIZATION.
S028Dec 11, 2008PROCESS CHANGE: MANUFACTURING/30-DAY NOTICECHANGE TO AN IN-PROCESS MANUFACTURING AID.
S026May 11, 2007CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACKAPPROVAL FOR THE REMOVAL OF A COATING ON THE INNER LUMEN OF THE EXTREME CATHETER MODEL NUMBERS 114-001, 117-002, AND 120-001, THE CHANGE TO BLACK TUBING FOR 0.9 MM CATHETER MODEL NUMBERS 110-003 AND 110-004 X-80, AND THE CHANGE IN THE STRAIN RELIEF MATERIAL DUROMETER FOR THE 0.9 MM EXTREME CATHETER MODEL NUMBERS 110-001, 110-002, 110-152 AND 0.7 MM EXTREME CATHETER MODEL 110-005 TO PREVENT KINKING AT THE STRAIN RELIEF.
S025Aug 02, 2006CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - SOFTWARE/REAL-TIME PROCESSAPPROVAL FOR A NEW SOFTWARE VERSION TO THE CVX-3000 EXCIMER LASER AND REVISED LABELING TO THE LASER CONSOLE.
S024Aug 08, 2003LABELING CHANGE - INSTRUCTIONS/NORMAL 180 DAY TRACKAPPROVAL FOR CHANGES TO INSTRUCTIONS FOR USE, INCLUDING CHANGES TO THE CONTRAINDICATIONS SECTION, FOR THE VITESSE COS RX, VITESSE E, AND EXTREME OTW CATHETERS.
S023May 02, 2003LABELING CHANGE - MINOR/NORMAL 180 DAY TRACK NO USER FEEAPPROVAL FOR THE REVISED INSTRUCTIONS FOR USE THAT INCLUDE THE ADJUDICATED RESULTS FROM THE LARS INVESTIGATION.
S021Feb 04, 2003CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - COMPONENT/NORMAL 180 DAY TRACKAPPROVAL FOR THE 0.7 MM SIZE OF THE EXTREME OTW X80 PERCUTANEOUS EXCIMER LASER CORONARY ANGIOPLASTY CATHETER.
S020Oct 10, 2001LABELING CHANGE - INDICATIONS/NORMAL 180 DAY TRACKAPPROVAL FOR AN ADDITIONAL INDICATION, THE TREATMENT OF RESTENOSIS IN 316L STAINLESS STEEL STENTS, PRIOR TO THE ADMINISTRATION OF INTRAVASCULAR BRACHYTHERAPY, FOR THE CVX-300 EXCIMER LASER CORONARY ANGIOPLASTY (ELCA) SYSTEM. THE INDICATION IS IN ADDITION TO THOSE LISTED IN THE FEBRUARY 19, 1993, APPROVAL LETTER.
S019Jun 19, 2001CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - SPECIFICATIONS/NORMAL 180 DAY TRACKVITESSE POINT 9MM X80 PERCUTANEOUS CORONARY ANGIOPLASTY CATHETER, MODEL 110-004, AND THE EXTREME POINT 9MM X80 PERCUTANEOUS CORONARY ANGIOPLASTY CATHETER, MODEL 110-002: 1) A CHANGE IN THE LASTING TIME FROM 5 SECONDS ON AND 10 SECONDS OFF TO 10 SECONDS ON AND 5 SECONDS OFF; 2) A CHANGE IN THE FLUENCE AND REPETITION RATE FROM 30-60 FLUENCE AND 25-40 HZ TO 30-80 FLUENCE AND 25-80 HZ; 3) A LABELING CHANGE FROM "LASER ADVANCEMENT OF APPROXIMATELY 1 MM PER SECOND" TO "MAINTAIN CONSTANT CATHETER TIP CONTACT WITH THE LESION BY APPLYING MILD FORWARD PRESSURE TO THE SHAFT OF THE CATHETER"; AND 4) A CHANGE IN THE PIN CODE ON THE COUPLER SO THAT THE CATHETERS INSTRUCT THE LASER SYSTEM TO ALLOW INCREASED LASING PARAMETERS.
S018Aug 04, 2000CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - COMPONENT/NORMAL 180 DAY TRACKAPPROVAL FOR THE VITESSE XTO 0.9 MM CORONARY ANGIOPLASTY CATHETER, MODEL 110-003.
S015Jul 11, 2000CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACKAPPROVAL FOR THE EXTREME 0.9 MM CORONARY ANGIOPLASTY CATHETER.
S017Mar 17, 2000PROCESS CHANGE: MANUFACTURING/135 REVIEW TRACK FOR 30-DAY NOTICEThe 135-day supplement requested approval for the addition of ethylene oxide sterilization equipment.
S014Jan 28, 2000CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - COMPONENT/NORMAL 180 DAY TRACKApproval is for the Vitesse-C OS Laser Angioplasty Cathethers, Models 114-009, 117-016, and 120-009.
S016Dec 10, 1999CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - SOFTWARE/NORMAL 180 DAY TRACKApproval for software modifications for the Power Error audible tone warning and Fault 10 display features.
S013Mar 12, 1999CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - SOFTWARE/NORMAL 180 DAY TRACKApproval for Software Versions 3.51 and 3.6.
S012Sep 24, 1997CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACKApproval for the 2.0 mm Vitesse(TM)-EII (Eccentric Monorail) Catheter, Model 120-008.
S005Jul 31, 1995CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACKAPPROVAL FOR VITESSE-E (MODEL 117-005) & VITESSE-E II (MODEL 117-205) CATHETERS TO BE USED WITH THE CVX-300 EXCIMER LASER SYSTEM ON ECCENTRIC LESIONS MEETING ONE OR MORE OF YOUR APPROVED INDICATIONS FOR USE
S008Jul 12, 1995CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - SOFTWARE/NORMAL 180 DAY TRACKAPPROVAL FOR UPGRADED SOFTWARE (VERSION 3.4) FOR THE SPECTRANETICS CVX-300 EXCIMER LASER SYSTEM
S010May 16, 1995LOCATION CHANGE - OTHER/NORMAL 180 DAY TRACK
S009Mar 24, 1995OTHER/NORMAL 180 DAY TRACK
S007Nov 15, 1994LABELING CHANGE - OTHER/NORMAL 180 DAY TRACK
S006Oct 31, 1994CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACK
S001Oct 18, 1993CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACK
S002Sep 23, 1993CHANGE DESIGN/COMPONENTS/SPECIFICATIONS - OTHER/NORMAL 180 DAY TRACK
Feb 19, 1993Original Approval APPROVAL FOR THE SPECTRANETICS CVX-300(TM) EXCIMER LASER SYSTEM, INCLUDING THE MODELS PC1014 AND PC1017 LASER CATHETERS. THIS SYSTEM IS INDICATED FOR USE IN PATIENTS WITH SINGLE OR MULTIVESSEL CORONARY ARTERY DISEASE EITHER AS A STAND ALONE MODALITY OR IN CONJUNCTION WITH PERCUTANEOUS TRANSLUMINAL CORONARY BALLOON ANGIOPLASTY (PTCA) AND WHO ARE ACCEPTABLE CANDIDATES FOR CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY. ADJUNCTIVE BALLOON ANGIOPLASTY WAS PERFORMED, AT THE CLINICAL INVESTIGATOR'S DISCRETION, IN 84 PERCENT OF THE LESIONS TREATED. CLINICAL EXPERIENCE HAS PROVIDED REASONABLE ASSURANCE THAT THE SPECTRANETICICS CVX-300(TM) EXCIMER LASER SYSTEM AND MULTIFIBER LASER CATHETERS ARE SAFE AND EFFECTIVE FOR THE FOLLOWING INDICATIONS:OCCLUDED SAPHENOUS VEIN BYPASS GRAFTS; OSTIAL LESIONS; LONG LESIONS (GREATER THAN 20 MM IN LENGTH); MODERATELY CALCIFIED STENOSES (HEAVILY CALCIFIED STENOSES ARE THOSE LESIONS THAT DEMONSTRATE COMPLETE CALCIFICATION WHEN IDENTIFIED UNDER FLUOROSCOPY PRIOR TO THE PROCEDURE. MODERATELY AND SLIGHTLY CALCIFIED STENOSES ARE ALL OTHERS.); TOTAL OCCLUSIONS TRAVERSABLE BY A GUIDEWIRE; AND LESIONS WHICH HAVE PREVIOUSLY FAILED BALLOON ANGIOPLASTY (THIS INCLUDES THOSE LESIONS THAT WERE TREATED UNSUCCESSFULLY BY PTCA. LESIONS THAT HAVE UNDERGONE A COMPLICATED PTCA PROCEDURE ARE NOT INCLUDED IN THIS CATEGORY.) THESE LESIONS MUST BE TRAVERSABLE BY A GUIDEWIRE AND COMPOSED OF ATHERSCLEROTIC PLAQUE AND/OR CALCIFIED MATERIAL. THE LESIONS SHOULD BE WELL DEFINED BY ANGIOGRAPHY.